ARCHIVES

FDA Approves Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 33 | September 14, 2007

Download PDF Visit The Full Archive

Related Articles

Freireich Blasts Prevention Advocates, Defends Treatment

September 15, 1978

Studies of Oncotype DX Test Presented at ASCO Symposium

January 31, 2014

IOM Report Links Agent Orange, CLL

January 24, 2003

Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds

November 28, 2008

Francis Collins Nominated For NIH Director Two Days After Final Stem Cell Guidelines Released.

July 10, 2009

Rauscher To Leave ACS when It Moves To Atlanta; Gadberry To Retire In March; Other VPs Stay On

January 8, 1988